Boston Trust Walden’s Merck MRK Stock Holding History

Boston Trust Walden’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.4M	Sell	447,062 -6,132	-1%	-$718K	0.44%	79
2026 Q1	$54.5M	Sell	453,194 -12,424	-3%	-$1.43M	0.45%	80
2025 Q4	$49M	Sell	465,618 -14,563	-3%	-$1.37M	0.37%	106
2025 Q3	$40.3M	Sell	480,181 -160,552	-25%	-$13.2M	0.3%	130
2025 Q2	$50.7M	Buy	640,733 +37,557	+6%	+$2.99M	0.36%	110
2025 Q1	$54.1M	Sell	603,176 -30,447	-5%	-$2.84M	0.4%	98
2024 Q4	$63M	Sell	633,623 -1,901	-0.3%	-$196K	0.44%	76
2024 Q3	$72.2M	Sell	635,524 -6,460	-1%	-$767K	0.5%	67
2024 Q2	$79.5M	Sell	641,984 -39,559	-6%	-$5.1M	0.59%	53
2024 Q1	$89.9M	Sell	681,543 -86,608	-11%	-$10.7M	0.64%	51
2023 Q4	$83.7M	Buy	768,151 +18,309	+2%	+$1.9M	0.63%	47
2023 Q3	$77.2M	Sell	749,842 -2,111	-0.3%	-$228K	0.65%	48
2023 Q2	$86.8M	Sell	751,953 -1,270	-0.2%	-$144K	0.71%	38
2023 Q1	$80.1M	Sell	753,223 -33,579	-4%	-$3.63M	0.69%	39
2022 Q4	$87.3M	Sell	786,802 -11,720	-1%	-$1.2M	0.77%	37
2022 Q3	$68.8M	Sell	798,522 -5,970	-0.7%	-$533K	0.68%	42
2022 Q2	$73.3M	Sell	804,492 -14,423	-2%	-$1.28M	0.69%	39
2022 Q1	$67.2M	Buy	818,915 +6,063	+0.7%	+$478K	0.56%	56
2021 Q4	$62.3M	Sell	812,852 -36,715	-4%	-$2.92M	0.5%	60
2021 Q3	$63.8M	Buy	849,567 +12,272	+1%	+$933K	0.57%	49
2021 Q2	$65.1M	Buy	837,295 +13,977	+2%	+$1.04M	0.58%	45
2021 Q1	$60.6M	Buy	823,318 +130,080	+19%	+$9.6M	0.59%	47
2020 Q4	$54.1M	Buy	693,238 +5,445	+0.8%	+$416K	0.58%	49
2020 Q3	$54.4M	Buy	687,793 +4,669	+0.7%	+$366K	0.68%	38
2020 Q2	$50.4M	Buy	683,124 +23,671	+4%	+$1.78M	0.68%	36
2020 Q1	$48.4M	Sell	659,453 -1,793	-0.3%	-$141K	0.77%	32
2019 Q4	$57.4M	Buy	661,246 +3,048	+0.5%	+$250K	0.67%	37
2019 Q3	$52.9M	Sell	658,198 -3,346	-0.5%	-$268K	0.66%	39
2019 Q2	$52.9M	Buy	661,544 +11,451	+2%	+$877K	0.69%	38
2019 Q1	$51.6M	Buy	650,093 +14,745	+2%	+$1.1M	0.7%	36
2018 Q4	$46.3M	Sell	635,348 -10,734	-2%	-$758K	0.74%	38
2018 Q3	$43.7M	Sell	646,082 -4,878	-0.7%	-$311K	0.6%	48
2018 Q2	$37.7M	Sell	650,960 -1,805	-0.3%	-$102K	0.55%	55
2018 Q1	$33.9M	Sell	652,765 -10,808	-2%	-$584K	0.51%	61
2017 Q4	$35.6M	Sell	663,573 -25,335	-4%	-$1.4M	0.52%	58
2017 Q3	$42.1M	Buy	688,908 +11,214	+2%	+$680K	0.66%	46
2017 Q2	$41.4M	Buy	677,694 +53,411	+9%	+$3.25M	0.67%	45
2017 Q1	$37.9M	Buy	624,283 +19,877	+3%	+$1.21M	0.59%	55
2016 Q4	$34M	Buy	604,406 +22,024	+4%	+$1.29M	0.54%	62
2016 Q3	$34.7M	Buy	582,382 +46,301	+9%	+$2.71M	0.57%	49
2016 Q2	$29.5M	Buy	536,081 +44,417	+9%	+$2.36M	0.5%	68
2016 Q1	$24.8M	Buy	491,664 +22,873	+5%	+$1.12M	0.43%	78
2015 Q4	$23.6M	Buy	468,791 +9,395	+2%	+$474K	0.44%	73
2015 Q3	$21.6M	Buy	459,396 +41,875	+10%	+$2.22M	0.36%	113
2015 Q2	$22.7M	Buy	417,521 +299,427	+254%	+$16.8M	0.35%	129
2015 Q1	$6.48M	Buy	118,094 +52,741	+81%	+$2.99M	0.1%	206
2014 Q4	$3.54M	Buy	65,353 +1,991	+3%	+$111K	0.05%	229
2014 Q3	$3.58M	Sell	63,362 -1,700	-3%	-$95.5K	0.06%	219
2014 Q2	$3.59M	Buy	65,062 +17,659	+37%	+$963K	0.05%	214
2014 Q1	$2.57M	Sell	47,403 -1,942	-4%	-$101K	0.04%	216
2013 Q4	$2.36M	Sell	49,345 -524	-1%	-$24K	0.03%	221
2013 Q3	$2.27M	Buy	49,869 +1,127	+2%	+$51.5K	0.03%	219
2013 Q2	$2.16M	Buy	+48,742	New	+$2.18M	0.03%	214

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Boston Trust Walden's MRK Position: Q2 2026 in Review

Boston Trust Walden reduced its Merck (MRK) stake by 1.4% in Q2 2026, selling an estimated $718K and leaving 447,062 shares worth $57.4M. The position accounts for 0.44% of the portfolio, ranked #79.

Boston Trust Walden first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $89.9M in Q1 2024. 1,477 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Boston Trust Walden held 447,062 shares of Merck worth $57.4M as of Q2 2026.
Boston Trust Walden sold 6,132 Merck shares in Q2 2026, an estimated $718K.
Merck made up 0.44% of Boston Trust Walden's portfolio in Q2 2026, its #79 holding.
Boston Trust Walden first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Boston Trust Walden's Merck position peaked at $89.9M in Q1 2024.
1,477 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.